The effect of hypertension and anti-hypertensive drugs on endometrial thickness and pathology

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 125, Issue 2, 2006, Pages 239-242

  Vorgias, George ^a   Strigou, Sonia ^b   Varhalama, Eugene ^a   Savvopoulos, Panagiotis ^a   Dertimas, Basil ^a   Akrivos, Thrassivoulos ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b INEGSEE Institute   (Greece)

Author keywords

Antihypertensive drugs; Endometrial; Endometrial pathology; Endometrium; Hyperplasia; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CURETTAGE; DRUG EFFECT; ENDOMETRIAL DISEASE; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOLOGY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPOTTING;

EID: 33645892886     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2005.07.031     Document Type: Article

References (14)

1. Adenocarcinoma of the uterus. In: Di Saia P., and Creasman W. (Eds). Clinical gynecologic oncology. 6th ed. (2002), St. Louis, Mosby 137
2. Brinton L.A., and Hoover R.N. Epidemiology of gynecologic cancers. In: Hoskins W., Perez C., and Young R. (Eds). Principles and practice of gynecologic oncology. 3rd ed. (2000), Lippincott Williams and Wilkins, Philadelphia 5-6
3. Brinton L.A., Berman M.L., Mortel R., et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case control study. Am J Obstet Gynecol 167 (1992) 1317
4. Elwood J.M., Cole P., Rothman K.J., et al. Epidemiology of endometrial cancer. J Natl Cancer Inst 59 (1977) 1055
5. Nasri M.N., Shepherd J.H., Stetchell AKE, Lowe D.G., and Chard T. The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 98 (1991) 470-475
6. Auslender R., Bornstein J., Dirnfeld M., Kogan O., Atad J., and Abramovici H. Vaginal ultrasonography in patients with postmenopausal bleeding. Ultrasound Obstet Gynecol 3 (1993) 426-428
7. Gronroos M., Salmi T.A., Vuento M.H., et al. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 71 4 (1993) 1279-1282
8. Serdar Serin I., Ozcelik B., Basbug M., Ozsahin O., Yilmazsoy A., and Erez R. Effects of hypertension and obesity on endometrial thickness. Eur J Obstet Gynecol Reprod Biol 109 1 (2003) 72-75
9. Bornstein J., Auslender R., Goldstein S., Kohan R., Stolar Z., and Abramovici H. Increased endometrial thickness in women with hypertension. Am J Obstet Gynecol 183 3 (2000) 583-587
10. Anastasiadis P.G., Skaphida P.G., Koutlaki N.G., Galazios G.C., Tsikouras P.N., and Liberis V.A. Descriptive epidemiology of endometrial hyperplasia I patients with abnormal uterine bleeding. Eur J Gynaecol Oncol 21 2 (2000) 131-134
11. Okman-Kilic T., and Kucuk M. The effects of antihypertensive agents on endometrial thickness in asymptomatic, hypertensive, postmenopausal women. Menopause 10 4 (2003) 362-365
12. Alcazar J.L. Endometrial sonographic findings in asymptomatic, hypertensive, postmenopausal women. J Clin Ultrasound 28 4 (2000) 175-178
13. Martinez-Rubio M.P., and Alcazar J.L. Ultrasonographic and pathological endometrial findings in asymptomatic postmenopausal women taking antihypertensive drugs. Maturitas 46 1 (2003) 27-32
14. Pardo J., Aschkenazi S., Kaplan B., Orvieto R., Notke S., and Ben-Rafael Z. Abnormal sonographic endometrial findings in asymptomatic postmenopausal women: possible role of antihypertensive drugs. Menopause 5 4 (1998) 223-225